Glaxosmithkline Share News (GSK)

Tuesday broker round-up UPDATE

Adept Telecom: Northland Capital revises target price from 145p to 165p and reiterates a buy recommendation. Aggreko: JP Morgan reduces target price from 1620p to 1505p, while its neutral recommendation remains unchanged. UBS cuts target price from 1610p to 1555p keeping its neutral rating. APR En

DIRECTOR DEALINGS: Glaxo Director Beneficiary Acquires American Depositary Shares

DIRECTOR DEALINGS: GlaxoSmithKline Connected Person Adds ADSs

Star fund manager exits can prove a blow to small caps

* Small caps seen vulnerable after Woodford leaves Invesco * Could take thousands of days to liquidate - Markit * Analysts urge caution in tracking 'star' managers By Tricia Wright LONDON, Oct 25 (Reuters) - Small companies favoured by top fund manager Neil Woodford risk s

HIV drugs may get new role in fighting cancer

By Ben Hirschler Oct 25 (Reuters) - A type of HIV medicine that stops the AIDS virus from entering immune system cells could in future be put to work against cancer in new combination therapies being developed by drug companies. Interest in using so-called CCR5 inhibitors to fight tum

UPDATE 1-EU agency backs new drugs from Actelion and Lundbeck

LONDON, Oct 25 (Reuters) - European regulators have recommended approval of Swiss firm Actelion's new pulmonary arterial hypertension drug Opsumit and a novel antidepressant called Brintellix from Denmark's Lundbeck . The green light for Opsumit comes hard on the heels of its approval in th

Glaxo Venture Submits European Application for Three-Drug HIV Pill

Laps to laptops: Formula One sells its big data know-how

By Jeremy Wagstaff SINGAPORE, Oct 25 (Reuters) - Wander around the pits at a Formula One car race and you're as likely to bump into a laptop-wielding scientist or engineer as a mechanic with a spanner. And the lessons they are drawing from sensors on F1 tracks, cars and drivers are fi

London close: Markets lifted by corporate earnings, China outlook

- FTSE 100 at levels not seen since May - China manufacturing PMI at seven-month high - Financials, miners and pharma stocks gain techMARK 2,642.27 +0.68% FTSE 100 6,713.18 +0.58% FTSE 250 15,526.93 +0.21% UK markets set a fresh five-month high on Thursday as investors celebrated an improved outlo

Sector movers: Shire gives pharma sector a boost after Q3 beat

Strong results from Shire injected some gains into the pharmaceuticals sector on Thursday after the company beat quarterly forecasts and hiked its guidance for the full year. The FTSE 100 specialty biopharmaceuticals stock was up an impressive 8.4% at 2,737p in afternoon trade following its results

UPDATE 2-With rivals focused on merger, WPP thumps forecasts

Broker snap: ECB stress tests to restore confidence in banks, says Credit Suisse

Creidit Suisse believes that the new round of stress tests by the European Central Bank (ECB) should improve confidence in European banks as it reiterated its 'overweight' position on the sector. The ECB on Wednesday outlined proposals for a year-long series of health checks on European banks, whic

Thursday broker round-up UPDATE

Aquarius Platinum: Investec lowers target price from 48p to 42p and downgrades from hold to sell. ASOS: Citi increases target price from 5800p to 7000p reiterating its buy recommendation. BHP Billiton: Jefferies raises target price from 2350p to 2400p and keeps a buy recommendation. Clinigen: Inv

BROKER RATING CHANGES: Four Brokers Raise Home Retail Price Target

Tuesday tips round-up: GlaxoSmithKline, Pace

GlaxoSmithKline's sales in China tumbled by 60 per cent in the third quarter, the company revealed on Wednesday, halving the country's contribution to Glaxo's total quarterly pharmaceutical sales in emerging markets when compared with year-ago levels. However, this hides the fact that the firm's ope